NeuExcell Therapeutics is a gene therapy company focusing on improving the lives of patients suffering from neurodegenerative diseases. We have discovered a disruptive technology that focuses on regenerating neurons in the brain. This powerful platform has the potential to transform patient outcomes and change lives.
We are now rapidly expanding our R&D efforts, toward our goal of developing effective and safe treatments for serious neurodegenerative diseases including stroke, Huntington’s Disease, ALS, and Traumatic Brain Injury.
Our experienced team is excited to dedicate themselves to contribute and bring innovative and effective treatments for those suffering from neurodegenerative conditions.
It is our goal to improve the quality of life of millions of patients worldwide by using the power of gene therapy to restore damaged neuronal tissue.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 411 Swedeland Rd, King Of Prussia,pennsylvania 19406,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.neuexcell.com
- HQ
- King of Prussia, Pennsylvania
Neuexcell Therapeutics Questions
Neuexcell Therapeutics's website is http://www.neuexcell.com
Neuexcell Therapeutics's LinkedIn profile is https://www.linkedin.com/company/neuexcell
Neuexcell Therapeutics has
10 employees.
View email and phone details for 10
employees at Neuexcell Therapeutics.
Neuexcell Therapeutics's industry is
Biotechnology Research
Neuexcell Therapeutics's top competitors are
Verismo Therapeutics,
Aro Biotherapeutics,
Immitra Bio Gmbh,
Accelerated Biosciences Corp.,
Rejuvenate Bio,
Epidarex Capital,
Spur Therapeutics,
Vintabio,
Brl Medicine 邦耀生物,
Exegenesis Bio.
Neuexcell Therapeutics's categories are Biotechnology Research
Neuexcell Therapeutics's founding year is 2016
